Literature DB >> 15624931

Chiral ligands derived from Abrine 8. An experimental and theoretical study of free ligand conformational preferences and the addition of diethylzinc to benzaldehyde.

H J Zhu1, J X Jiang, S Saebo, C U Pittman.   

Abstract

Three structurally similar series of 1,2,3,4-tetrahydro-beta-carboline ligands, 4a-d, 6a-d and 7a-d, and two series of chiral oxazolidines, 8a-d and 9a-g, were synthesized and used as chiral catalysts in the addition of diethylzinc to benzaldehyde. The enantioselectivities of the resulting 1-phenyl-1-propanol were obtained in each case, and these ee values were, in most cases, related to the conformational populations of the free ligand as expressed by the calculated differences in the energies of the ligand conformations formed by inversion at nitrogen. This suggested the possible existence of a linear free energy relationship. The effect on enantioselectivity of the carbon chain length of the R group located (1) on the C-3 substituent of 4a-d, 6a-d, and 7a-d or (2) at C-5 in 8a-d and 9a-g was studied in detail. On the basis of the correlations observed and the ligands' structural characterization, a structure was proposed for the transition state during ethyl group transfer when using ligands 8a-d. Furthermore, the change in enantioselectivity was successfully predicted when diastereomeric ligands 11 and 12 were compared in this chiral addition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15624931     DOI: 10.1021/jo049754c

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  1 in total

1.  Pseudo-resonance structures in chiral alcohols and amines and their possible aggregation states.

Authors:  Huajie Zhu; Shengnan Li; Yunjing Jia; Juxing Jiang; Feiliu Hu; Longfei Li; Fei Cao; Xiaoke Wang; Shenhui Li; Guanghui Ouyang; Gengfang Tian; Ke Gong; Guangjin Hou; Wei He; Zheng Zhao; Charles U Pittman; Feng Deng; Minghua Liu; Kai Sun; Ben Zhong Tang
Journal:  Front Chem       Date:  2022-08-29       Impact factor: 5.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.